▲ Peaking
Business
🔮 holds
Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs
Scribe Therapeutics files for $75 million IPO to test public appetite for early-stage biotechs
Nasdaq IPO By Investing.com
1 news trends Newsylist has tracked involving Nasdaq IPO By Investing.com — newest first.